Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Farmers Insurance
Cantor Fitzgerald
Johnson and Johnson
Medtronic
Covington

Generated: July 20, 2019

DrugPatentWatch Database Preview

Patent: 8,367,699

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,367,699
Title:Tetrahydro-isoquinolines
Abstract: The present invention provides a compound selected from compounds of formula (A) as ligand binding to the HDM2 protein, inducing apoptosis and inhibiting proliferation, and having therapeutic utility in cancer therapy and prevention. Compounds of formula (A) can be used as therapeutics for treating stroke, myocardial infarction, ischemia, multi-organ failure, spinal cord injury, Alzheimer\'s Disease, injury from ischemic events and heart valvular degenerative disease. Moreover, compounds of formula (A) can be used to decrease the side effects from cytotoxic cancer agents, radiation and to treat viral infections. ##STR00001##
Inventor(s): Weber; Lutz (Germering, DE), Khazak; Vladimir (Brooklyn, NY), Ross; Gunther (Munich, DE), Kalinski; Cedric (Munich, DE), Burdack; Christoph (Munich, DE)
Assignee: NexusPharma, Inc. (Langhorne, PA)
Application Number:12/441,266
Patent Claims:see list of patent claims

Details for Patent 8,367,699

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Try a Free Trial NexusPharma, Inc. (Langhorne, PA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Queensland Health
Accenture
Baxter
Citi
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.